This hybrid symposium, sponsored by the Nationwide Children’s Hospital Division of Hematology, Oncology, and Blood & Marrow Transplant, in collaboration with Department of Pathology and the Institute for Genomic Medicine, will provide a comprehensive 3-day overview of current and developing diagnostic and therapeutic approaches, allowing pediatric oncology teams to integrate these new tools at each stage of care of children with cancer.
Intended Audience
This conference is designed for physicians and researchers at all levels of training, nurse practitioners, pharmacists, nursing, psychosocial services, and other members of patient care teams.
Topics Will Include:
Day 1 Sessions | Day 2 and 3 Sessions | |
Topics |
|
|